International Biotechnology Trust PLC Global Blood Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$22.3 - $37.39 $3.39 Million - $5.68 Million	-151,800 Closed	0 $0
Q1 2022 May 20, 2022	BUY	$25.68 - $35.59 $1.46 Million - $2.03 Million	57,000 Added 60.13%	151,800 $5.26 Million
Q4 2021 Feb 15, 2022	BUY	$24.9 - $40.26 $1.82 Million - $2.94 Million	73,000 Added 334.86%	94,800 $2.77 Million
Q3 2020 Dec 01, 2020	BUY	$52.76 - $74.49 $633,120 - $893,879	12,000 Added 122.45%	21,800 $1.2 Million
Q1 2020 May 18, 2020	SELL	$41.72 - $87.2 $554,876 - $1.16 Million	-13,300 Reduced 57.58%	9,800 $498,000
Q4 2019 May 18, 2020	BUY	$45.7 - $81.86 $210,220 - $376,556	4,600 Added 24.86%	23,100 $1.84 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $430,825 - $550,145	-9,500 Reduced 33.93%	18,500 $897,000
Q1 2019 May 14, 2019	BUY	$39.99 - $53.48 $1.12 Million - $1.5 Million	28,000 New	28,000 $1.48 Million
Q3 2017 Mar 02, 2018	SELL	$25.1 - $31.05 $514,550 - $636,525	-20,500 Closed	0 $0
Q2 2017 Mar 02, 2018	SELL	N/A	-37,500 Reduced 64.66%	20,500 $561,000
Q1 2017 Mar 02, 2018	BUY	N/A	58,000	58,000 $2.13 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.